Home » Newsletters » BioWorld Science

BioWorld Science

May 8, 2015

View Archived Issues

Indivior presents phase III results for once-a-month risperidone in schizophrenia

Portola collaborates with Ora on development of PRT-2761 for ophthalmic diseases

Specific Treg inhibition enhances antitumoral effect of DC vaccination in HCC

NanoString Technologies and CITN collaborate on biomarkers for cancer immunotherapy

Pacific Biosciences achieves new milestone in Roche collaboration

World Lupus Day May 10th: Natural product astilbin shows promise in animal model

Transition Therapeutics licenses SARM TT-701 from Lilly

Silver Creek Pharmaceuticals receives grant to develop Smart Growth Factors

Alexion to acquire Synageva

Lundbeck updates progress of first quarter 2015

Preclinical and first clinical data reported for cancer candidate PQR-309

Transplant Genomics awards grant to study organ transplant biomarkers

Symbiomix Therapeutics reports results from phase II trial of SYM-1219 in bacterial vaginosis

BGB-283 shows promising antitumor activity

Phosphate Therapeutics releases phase II results for PT-20 in hyperphosphatemia

EMA committee recommends approval of new Orfadin formulations

Takeda patents OX1 receptor antagonists

Zealand Pharma and Boehringer Ingelheim disclose glucagon analogues

Hospital for Special Surgery reports compositions to promote tissue mineralization

Roche reports development of tau-PET imaging agents

Retinitis pigmentosa gene slc7a14 plays relevant role in vision

Venetoclax receives breakthrough therapy designation in 17p deletion CLL

Sumitomo Dainippon Pharma and Takeda terminate lurasidone agreement

Gilead Sciences acquires EpiTherapeutics

Sucampo's cobiprostone granted fast track designation for oral mucositis

PlasmaTech to acquire Abeona Therapeutics

Zykadia approved in E.U. for ALK-positive NSCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...